Pharmacokinetics and Safety of Inhaled Ivermectin in Mice as a Potential COVID-19 Treatment

{ 'indexed': {'date-parts': [[2022, 3, 19]], 'date-time': '2022-03-19T16:41:59Z', 'timestamp': 1647708119160}, 'reference-count': 31, 'publisher': 'Elsevier BV', 'license': [ { 'start': { 'date-parts': [[2022, 3, 1]], 'date-time': '2022-03-01T00:00:00Z', 'timestamp': 1646092800000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}], 'content-domain': {'domain': [], 'crossmark-restriction': False}, 'short-container-title': ['International Journal of Pharmaceutics'], 'published-print': {'date-parts': [[2022, 3]]}, 'DOI': '10.1016/j.ijpharm.2022.121688', 'type': 'journal-article', 'created': {'date-parts': [[2022, 3, 19]], 'date-time': '2022-03-19T00:25:09Z', 'timestamp': 1647649509000}, 'page': '121688', 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': ['Pharmacokinetics and Safety of Inhaled Ivermectin in Mice as a Potential COVID-19 Treatment'], 'prefix': '10.1016', 'author': [ {'given': 'Ahmed H.', 'family': 'Albariqi', 'sequence': 'first', 'affiliation': []}, {'given': 'Yuncheng', 'family': 'Wang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Rachel', 'family': 'Yoon Kyung Chang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Diana H.', 'family': 'Quan', 'sequence': 'additional', 'affiliation': []}, {'given': 'Xiaonan', 'family': 'Wang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Stefanie', 'family': 'Kalfas', 'sequence': 'additional', 'affiliation': []}, {'given': 'John', 'family': 'Drago', 'sequence': 'additional', 'affiliation': []}, {'given': 'Warwick J.', 'family': 'Britton', 'sequence': 'additional', 'affiliation': []}, {'given': 'Hak-Kim', 'family': 'Chan', 'sequence': 'additional', 'affiliation': []}], 'member': '78', 'reference': [ { 'key': '10.1016/j.ijpharm.2022.121688_b0005', 'first-page': '1', 'article-title': 'Preparation and Characterisation of inhalable ivermectin powders as a ' 'potential COVID-19 therapy', 'volume': '35', 'author': 'Albariqi', 'year': '2022', 'journal-title': 'J. Aerosol Med. Pulm. Drug Deliv.'}, { 'issue': '7889', 'key': '10.1016/j.ijpharm.2022.121688_b0010', 'doi-asserted-by': 'crossref', 'first-page': '367', 'DOI': '10.1038/d41586-021-03672-3', 'article-title': 'Omicron likely to weaken COVID vaccine protection', 'volume': '600', 'author': 'Callaway', 'year': '2021', 'journal-title': 'Nature'}, { 'key': '10.1016/j.ijpharm.2022.121688_b0015', 'doi-asserted-by': 'crossref', 'first-page': '104787', 'DOI': '10.1016/j.antiviral.2020.104787', 'article-title': 'The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 ' 'in vitro', 'volume': '178', 'author': 'Caly', 'year': '2020', 'journal-title': 'Antiviral Res.'}, { 'key': '10.1016/j.ijpharm.2022.121688_b0020', 'doi-asserted-by': 'crossref', 'first-page': '17073', 'DOI': '10.1038/s41598-020-74084-y', 'article-title': 'Nebulized ivermectin for COVID-19 and other respiratory diseases, a ' 'proof of concept, dose-ranging study in rats', 'volume': '10', 'author': 'Chaccour', 'year': '2020', 'journal-title': 'Sci. Rep.'}, { 'key': '10.1016/j.ijpharm.2022.121688_b0025', 'doi-asserted-by': 'crossref', 'first-page': '161', 'DOI': '10.1186/s12936-017-1801-4', 'article-title': 'Ivermectin to reduce malaria transmission I. Pharmacokinetic and ' 'pharmacodynamic considerations regarding efficacy and safety', 'volume': '16', 'author': 'Chaccour', 'year': '2017', 'journal-title': 'Malar. J.'}, { 'issue': '4', 'key': '10.1016/j.ijpharm.2022.121688_b0030', 'doi-asserted-by': 'crossref', 'first-page': '944', 'DOI': '10.1016/j.jhep.2021.01.032', 'article-title': 'EASL position paper on the use of COVID-19 vaccines in patients with ' 'chronic liver diseases, hepatobiliary cancer and liver transplant ' 'recipients', 'volume': '74', 'author': 'Cornberg', 'year': '2021', 'journal-title': 'J. Hepatol.'}, { 'key': '10.1016/j.ijpharm.2022.121688_b0035', 'doi-asserted-by': 'crossref', 'unstructured': 'Dinesh Kumar, N., Ter Ellen, B.M., Bouma, E.M., Troost, B., van de Pol, ' 'D.P.I., van der Ende-Metselaar, H.H., van Gosliga, D., Apperloo, L., ' 'Carpaij, O.A., van den Berge, M., Nawijn, M.C., Stienstra, Y., ' 'Rodenhuis-Zybert, I.A., Smit, J.M., 2021. Moxidectin and Ivermectin ' 'Inhibit Sars-Cov-2 Replication in Vero E6 Cells but Not in Human Primary ' 'Airway Epithelium Cells. Antimicrob. Agents Chemother., AAC0154321.', 'DOI': '10.1101/2021.05.17.444467'}, { 'issue': '6', 'key': '10.1016/j.ijpharm.2022.121688_b0040', 'doi-asserted-by': 'crossref', 'first-page': '2501', 'DOI': '10.1016/j.xphs.2021.01.017', 'article-title': 'Safety and Pharmacokinetic Assessments of a Novel Ivermectin Nasal ' 'Spray Formulation in a Pig Model', 'volume': '110', 'author': 'Errecalde', 'year': '2021', 'journal-title': 'J. Pharm. Sci.'}, { 'issue': '3', 'key': '10.1016/j.ijpharm.2022.121688_b0045', 'doi-asserted-by': 'crossref', 'first-page': '302', 'DOI': '10.3390/pharmaceutics13030302', 'article-title': 'Drug Repurposing in the COVID-19 Era: Insights from Case Studies ' 'Showing Pharmaceutical Peculiarities', 'volume': '13', 'author': 'Gatti', 'year': '2021', 'journal-title': 'Pharmaceutics'}, { 'issue': '6', 'key': '10.1016/j.ijpharm.2022.121688_b0050', 'doi-asserted-by': 'crossref', 'first-page': '393', 'DOI': '10.1177/0018578718758972', 'article-title': 'A Case of Ivermectin-Induced Warfarin Toxicity: First Published Report', 'volume': '53', 'author': 'Gilbert', 'year': '2018', 'journal-title': 'Hosp. Pharm.'}, { 'key': '10.1016/j.ijpharm.2022.121688_b0055', 'doi-asserted-by': 'crossref', 'first-page': '1122', 'DOI': '10.1177/009127002401382731', 'article-title': 'Safety, tolerability, and pharmacokinetics of escalating high doses of ' 'ivermectin in healthy adult subjects', 'volume': '42', 'author': 'Guzzo', 'year': '2002', 'journal-title': 'J. Clin. Pharmacol.'}, { 'key': '10.1016/j.ijpharm.2022.121688_b0060', 'series-title': 'Covid-19 vaccines and variants of concern: A review', 'first-page': 'e2313', 'author': 'Hadj Hassine', 'year': '2021'}, { 'key': '10.1016/j.ijpharm.2022.121688_b0065', 'unstructured': 'Johns Hopkins University, 2021. COVID-19 Map - Johns Hopkins Coronavirus ' 'Resource Center.'}, { 'issue': '3-4', 'key': '10.1016/j.ijpharm.2022.121688_b0070', 'doi-asserted-by': 'crossref', 'first-page': '251', 'DOI': '10.1016/j.vetpar.2004.11.028', 'article-title': 'Influence of the route of administration on efficacy and tissue ' 'distribution of ivermectin in goat', 'volume': '128', 'author': 'Lespine', 'year': '2005', 'journal-title': 'Vet. Parasitol.'}, { 'issue': '4', 'key': '10.1016/j.ijpharm.2022.121688_b0075', 'doi-asserted-by': 'crossref', 'first-page': '327', 'DOI': '10.1016/S0304-4017(99)00175-2', 'article-title': 'Comparative distribution of ivermectin and doramectin to parasite ' 'location tissues in cattle', 'volume': '87', 'author': 'Lifschitz', 'year': '2000', 'journal-title': 'Vet. Parasitol.'}, { 'issue': '3', 'key': '10.1016/j.ijpharm.2022.121688_b0080', 'doi-asserted-by': 'crossref', 'first-page': '662', 'DOI': '10.1016/j.antiviral.2013.10.004', 'article-title': 'Nuclear import and export inhibitors alter capsid protein distribution ' 'in mammalian cells and reduce Venezuelan Equine Encephalitis Virus ' 'replication', 'volume': '100', 'author': 'Lundberg', 'year': '2013', 'journal-title': 'Antiviral Res.'}, { 'key': '10.1016/j.ijpharm.2022.121688_b0085', 'doi-asserted-by': 'crossref', 'first-page': '55', 'DOI': '10.1016/j.antiviral.2018.09.010', 'article-title': 'Ivermectin inhibits DNA polymerase UL42 of pseudorabies virus entrance ' 'into the nucleus and proliferation of the virus in vitro and vivo', 'volume': '159', 'author': 'Lv', 'year': '2018', 'journal-title': 'Antiviral Res.'}, { 'key': '10.1016/j.ijpharm.2022.121688_b0090', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.intimp.2021.108004', 'article-title': 'Safety of inhaled ivermectin as a repurposed direct drug for treatment ' 'of COVID-19: A preclinical tolerance study', 'volume': '99', 'author': 'Mansour', 'year': '2021', 'journal-title': 'Int. Immunopharmacol.'}, { 'issue': '8', 'key': '10.1016/j.ijpharm.2022.121688_b0095', 'doi-asserted-by': 'crossref', 'first-page': '1884', 'DOI': '10.1093/jac/dks147', 'article-title': 'Ivermectin is a potent inhibitor of flavivirus replication specifically ' 'targeting NS3 helicase activity: new prospects for an old drug', 'volume': '67', 'author': 'Mastrangelo', 'year': '2012', 'journal-title': 'J. Antimicrob. Chemother.'}, { 'key': '10.1016/j.ijpharm.2022.121688_b0100', 'unstructured': 'Merck Sharp & Dohme BV Stromectol (Ivermectin): Product Information. ' 'Merck 2018 Sharp & Dohme Corp., Netherlands'}, { 'issue': '1', 'key': '10.1016/j.ijpharm.2022.121688_b0105', 'doi-asserted-by': 'crossref', 'first-page': 'e92', 'DOI': '10.1016/S2214-109X(19)30453-X', 'article-title': 'Safety of oral ivermectin during pregnancy: a systematic review and ' 'meta-analysis', 'volume': '8', 'author': 'Nicolas', 'year': '2020', 'journal-title': 'Lancet Glob Health'}, { 'issue': '2', 'key': '10.1016/j.ijpharm.2022.121688_b0110', 'doi-asserted-by': 'crossref', 'first-page': '91', 'DOI': '10.1016/j.ijantimicag.2007.08.023', 'article-title': 'Ivermectin: 25 years and still going strong', 'volume': '31', 'author': 'Õmura', 'year': '2008', 'journal-title': 'Int J Antimicrob Agents'}, { 'issue': '9', 'key': '10.1016/j.ijpharm.2022.121688_b0115', 'doi-asserted-by': 'crossref', 'first-page': '445', 'DOI': '10.1016/j.pt.2014.07.005', 'article-title': 'Ivermectin: panacea for resource-poor communities?', 'volume': '30', 'author': 'Ōmura', 'year': '2014', 'journal-title': 'Trends Parasitol'}, { 'key': '10.1016/j.ijpharm.2022.121688_b0120', 'doi-asserted-by': 'crossref', 'first-page': '141', 'DOI': '10.1016/j.pharmthera.2017.04.003', 'article-title': 'Inhaled efficacious dose translation from rodent to human: A ' 'retrospective analysis of clinical standards for respiratory diseases', 'volume': '178', 'author': 'Phillips', 'year': '2017', 'journal-title': 'Pharmacol. Ther.'}, { 'issue': '1-2', 'key': '10.1016/j.ijpharm.2022.121688_b0125', 'doi-asserted-by': 'crossref', 'first-page': '1', 'DOI': '10.1016/j.ijpharm.2010.03.017', 'article-title': 'Formulation strategy and use of excipients in pulmonary drug delivery', 'volume': '392', 'author': 'Pilcer', 'year': '2010', 'journal-title': 'Int. J. Pharm.'}, { 'key': '10.1016/j.ijpharm.2022.121688_b0130', 'doi-asserted-by': 'crossref', 'article-title': 'Intratracheal Administration of Dry Powder Formulation in Mice', 'author': 'Qiu', 'year': '2020', 'journal-title': 'J Vis Exp.', 'DOI': '10.3791/61469'}, { 'key': '10.1016/j.ijpharm.2022.121688_b0135', 'doi-asserted-by': 'crossref', 'unstructured': 'M. Sallam COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic ' 'Review of Vaccine Acceptance Rates 2021 Vaccines (Basel) 9', 'DOI': '10.1101/2020.12.28.20248950'}, { 'key': '10.1016/j.ijpharm.2022.121688_b0140', 'doi-asserted-by': 'crossref', 'first-page': '2', 'DOI': '10.1159/000056764', 'article-title': 'Lung lining liquid - the hidden depths. The 5th Nils W. Svenningsen ' 'memorial lecture', 'volume': '81 Suppl 1', 'author': 'Walters', 'year': '2002', 'journal-title': 'Biol. Neonate'}, { 'key': '10.1016/j.ijpharm.2022.121688_b0145', 'unstructured': 'World Health Organization, 2021. Tracking SARS-CoV-2 variants.'}, { 'issue': '10278', 'key': '10.1016/j.ijpharm.2022.121688_b0150', 'doi-asserted-by': 'crossref', 'first-page': '1023', 'DOI': '10.1016/S0140-6736(21)00306-8', 'article-title': 'Challenges in ensuring global access to COVID-19 vaccines: production, ' 'affordability, allocation, and deployment', 'volume': '397', 'author': 'Wouters', 'year': '2021', 'journal-title': 'Lancet'}, { 'issue': '3', 'key': '10.1016/j.ijpharm.2022.121688_b0155', 'doi-asserted-by': 'crossref', 'first-page': '306', 'DOI': '10.1016/j.cmpb.2010.01.007', 'article-title': 'PKSolver: An add-in program for pharmacokinetic and pharmacodynamic ' 'data analysis in Microsoft Excel', 'volume': '99', 'author': 'Zhang', 'year': '2010', 'journal-title': 'Comput. Methods Programs Biomed.'}], 'container-title': ['International Journal of Pharmaceutics'], 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S0378517322002435?httpAccept=text/xml', 'content-type': 'text/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://api.elsevier.com/content/article/PII:S0378517322002435?httpAccept=text/plain', 'content-type': 'text/plain', 'content-version': 'vor', 'intended-application': 'text-mining'}], 'deposited': { 'date-parts': [[2022, 3, 19]], 'date-time': '2022-03-19T00:25:26Z', 'timestamp': 1647649526000}, 'score': 1, 'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S0378517322002435'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2022, 3]]}, 'references-count': 31, 'alternative-id': ['S0378517322002435'], 'URL': 'http://dx.doi.org/10.1016/j.ijpharm.2022.121688', 'relation': {}, 'ISSN': ['0378-5173'], 'issn-type': [{'value': '0378-5173', 'type': 'print'}], 'subject': ['Pharmaceutical Science'], 'published': {'date-parts': [[2022, 3]]}, 'article-number': '121688'}